Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U9LT
|
||||
Former ID |
DIB016819
|
||||
Drug Name |
Y-39983
|
||||
Synonyms |
RKI-983; SNJ-1656; ROCK inhibitors, Mitsubishi Tanabe Pharma/Senju/Novartis; Rho-associated protein kinase inhibitors, Mitsubishi Tanabe Pharma/Senju/Novartis
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Glaucoma [ICD9: 365; ICD10:H40-H42] | Phase 1/2 | [522584] | ||
Company |
Mitsubishi Pharma Corp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H18Cl2N4O
|
||||
Canonical SMILES |
c1c(ccc(c1)C(=O)Nc1ccnc2c1cc[nH]2)[C@@H](C)N.Cl
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Rho associated protein kinase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.